Vascular Biogenics Ltd. (also Known as Vbl Therapeutics)

VBL Therapeutics is a publicly traded (NASDAQ: VBLT), clinical stage biotechnology company committed to the discovery, development and commercialization of next-generation, targeted medicines for difficult-to-treat medical conditions.